S. 3220 · 118th Congress (2023–2025)
A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.
This bill expands the priority-review voucher program for tropical diseases to include coccidioidomycosis (also known as Valley fever). A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 3220’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Mark Kelly (D-AZ)
- Cosponsors
4 cosponsors
1 original · 3 later
- Sen. Kyrsten Sinema (I-AZ)· Original · Nov 2, 2023
- Sen. Markwayne Mullin (R-OK)· Later · Dec 6, 2023
- Sen. John W. Hickenlooper (D-CO)· Later · Jan 31, 2024
- Sen. Jeff Merkley (D-OR)· Later · Mar 6, 2024
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (1)
A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.
Display title, Official title · Introduced in Senate